xaluprine (previously mercaptopurine nova laboratories)
nova laboratories ireland limited - monohydrat 6-merkaptopuryny - białaczka, limfoidalna - Środki przeciwnowotworowe - xaluprine jest wskazany w leczeniu ostrej białaczki limfoblastycznej (all) u dorosłych, młodzieży i dzieci.
xromi
nova laboratories ireland limited - hydroksymocznik - anemia, sickle cell - Środki przeciwnowotworowe - profilaktyka naczyń zgryzu powikłań sierp komórka anemia u pacjentów w wieku powyżej 2 lat.
qaialdo
nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 i 5.
betnovate n (1,22 mg + 5 mg)/g maść
glaxosmithkline (ireland) limited - betamethasoni valeras + neomycini sulfas - maść - (1,22 mg + 5 mg)/g
betnovate c (1,22 mg + 30 mg)/g maść
glaxosmithkline (ireland) limited - betamethasoni valeras + clioquinolum - maść - (1,22 mg + 30 mg)/g
betnovate c (1,22 mg + 30 mg)/g krem
glaxosmithkline (ireland) limited - betamethasoni valeras + clioquinolum - krem - (1,22 mg + 30 mg)/g
betnovate n (1,22 mg + 5 mg)/g krem
glaxosmithkline (ireland) limited - betamethasoni valeras + neomycini sulfas - krem - (1,22 mg + 5 mg)/g
betnovate 1,22 mg/g krem
glaxosmithkline (ireland) limited - betamethasoni valeras - krem - 1,22 mg/g
betnovate 1,22 mg/g maść
glaxosmithkline (ireland) limited - betamethasoni valeras - maść - 1,22 mg/g
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - antygeny powierzchniowe wirusa grypy (hemaglutynina i neuraminidaza) szczepu a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - szczepionki - aktywna immunizacja przeciwko podtypowi h5n1 wirusa grypy a.. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.